Please login to the form below

Not currently logged in
Email:
Password:

drug launch

This page shows the latest drug launch news and features for those working in and with pharma, biotech and healthcare.

Embattled Biogen talks up Aduhelm

Embattled Biogen talks up Aduhelm

They are: to improve understanding of Aduhelm clinical data across the board, to expedite the development of the infrastructure necessary to launch the drug and to seek to clarify the reimbursement ... The number of doctors that are currently prescribing

Latest news

More from news
Approximately 1 fully matching, plus 204 partially matching documents found.

Latest Intelligence

  • The secret to a successful brand launch: being in it together The secret to a successful brand launch: being in it together

    There are many insights, recommendations and strategies about what the ingredients for a successful launch are, yet nearly 50% of drug launches underperform against expectations. ... Agencies are in a rare position, having honed and evolved their launch

  • Reaching patients and HCPs during the pandemic Reaching patients and HCPs during the pandemic

    Nexlizet, and Esperion was even able to accelerate the launch of the therapy by one month. ... While Horizon was fortunate enough to launch its bulging eye drug, Tepezza, in January 2020, the pandemic still hit at a critical time for any new drug.

  • Successful product commercialisation: what can we learn from the rare disease setting? Successful product commercialisation: what can we learn from the rare disease setting?

    Achieving launch success in an increasingly challenging commercial environment. The pharmaceutical industry is constantly evaluating opportunities to accelerate product life cycles and bring efficiencies to drug discovery, development and

  • Alzheimer’s: the search for a cure Alzheimer’s: the search for a cure

    However, the situation has changed dramatically since then, with Biogen preparing for a drug launch that could make aducanumab a blockbuster and reinvigorate interest in amyloid beta. ... A lot is resting on the US Food and Drug Administration’s (FDA)

  • Cooking up a co-creation feast – beyond vanilla Cooking up a co-creation feast – beyond vanilla

    Another challenge for us as agencies is to nudge our clients to involve the end user earlier and earlier in the drug development process. ... Often, we co-design material to support the use of a drug during its clinical development.

More from intelligence
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest appointments

  • NDA Group appoints Alison McGregor as its principal consultant NDA Group appoints Alison McGregor as its principal consultant

    She joins the group following a new US office launch. Drug development consultancy, NDA Group, has appointed Alison McGregor as its principal consultant following the opening of its new US office

  • Medicines Discovery Catapult appoints CEO Medicines Discovery Catapult appoints CEO

    Chris' experience of leading companies operating in life sciences combined with his in-depth knowledge of drug discovery will be of tremendous value to the company.”. ... The Catapult will engage the UK's experienced drug discovery talent and help

  • Astellas promotes John Demaree Astellas promotes John Demaree

    Demaree was promoted from his position as executive director of oncology marketing, where he oversaw the launch of prostate cancer drug Xtandi (enzalutamide) and promotion of lung cancer therapy Tarceva (erlotinib).

  • Paolo Paoletti named as executive chairman of Kesios Paolo Paoletti named as executive chairman of Kesios

    Paoletti was formerly the first appointed president of GSK Oncology, where he was responsible for the overall oncology business within the firm and oversaw activities from early drug discovery through to ... clinical development, launch and life cycle

  • Purdue looks to Merck for new CEO Purdue looks to Merck for new CEO

    His previous roles include president of Merck US, during which time he helped to launch the hepatitis C drug Victrelis (boceprevir) and led the acquisition of ophthalmology company Inspire Pharmaceuticals.

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...